![Yvonne McGrath](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yvonne McGrath
Chief Tech/Sci/R&D Officer at
ITEOS THERAPEUTICS, INC.
Profile
Yvonne McGrath currently works at iTeos Therapeutics, Inc., as Chief Scientific Officer from 2022.
Dr. McGrath also formerly worked at Complix NV, as Director & Chief Scientific Officer from 2014 to 2020, Immunocore Holdings Plc, as Head-Development from 2010 to 2014, and Immunocore Ltd., as Head-Development from 2010 to 2014.
Dr. McGrath received her undergraduate degree from Queen’S University Belfast and doctorate degree from Cardiff University School of Medicine.
Yvonne McGrath active positions
| Companies | Position | Start |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/04/2020 |
Former positions of Yvonne McGrath
| Companies | Position | End |
|---|---|---|
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Chief Tech/Sci/R&D Officer | 31/03/2020 |
| IMMUNOCORE HOLDINGS PLC | Corporate Officer/Principal | 31/03/2014 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Corporate Officer/Principal | 31/03/2014 |
Training of Yvonne McGrath
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Health Technology |
Cardiff University School of Medicine
 Cardiff University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Queen’S University Belfast
 Queen’S University Belfast Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
- Stock Market
- Insiders
- Yvonne McGrath
